Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:34:11.740Z.
Calculation as of: 2026-10-06T17:34:11.740Z.
Quote observation: 2026-10-06T17:30:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 680db3c2305e98602fe5277f15244516f30a0ab53cbf5830e5b41f5092839f7c
EARNINGS YIELD
N/A
Market Cap
$860.24M
Earnings Yield
N/A
TTM Avg
2.57%
3Y Avg
2.57%
5Y Avg
2.57%
Market Cap
$859.24M
Earnings Yield
35.14%
TTM Avg
38.06%
3Y Avg
23.44%
5Y Avg
23.44%
Market Cap
$845.91M
Earnings Yield
N/A
TTM Avg
3.42%
3Y Avg
14.26%
5Y Avg
9.75%
Market Cap
$833.66M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$880.50M
Earnings Yield
17.51%
TTM Avg
17.36%
3Y Avg
17.36%
5Y Avg
17.36%
Market Cap
$832.81M
Earnings Yield
N/A
TTM Avg
2.16%
3Y Avg
2.16%
5Y Avg
2.16%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SL Science Holding Ltd (SLBT) | $864.30M | N/A | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $860.24M | N/A | 2.57% | 2.57% | 2.57% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $859.24M | 35.14% | 38.06% | 23.44% | 23.44% |
| SI-BONE, Inc. (SIBN)vs › | $860.05M | N/A | N/A | N/A | N/A |
| QuidelOrtho Corporation (QDEL)vs › | $845.91M | N/A | 3.42% | 14.26% | 9.75% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $833.66M | N/A | N/A | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $880.50M | 17.51% | 17.36% | 17.36% | 17.36% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $832.81M | N/A | 2.16% | 2.16% | 2.16% |
| Beta Bionics, Inc. (BBNX)vs › | $830.51M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $830.36M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
